Chronic Kidney Disease Stage 3A

1

Review clinical trials related to Chronic Kidney Disease Stage 3A. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)

The KDOQI 2020 - Clinical practice guideline for nutrition in chronic kidney disease (CKD) -recommends protein restriction to reduce the risk of end-stage renal disease/death and improve quality of life, a low protein diet providing 0.55-0.60g dietary protein/ kg body weight/day is recommended. FLAVIS® is a product line of hypoprotein foods specially developed for the treatment of CKD.The use of low-protein foods may facilitate the achievement of nutritional goals in terms of protein intake and help patients to follow a low-protein diet.

Participants needed: 244
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Dr. Schär AG / SPAUpdated: Jan 29, 2025Locations: 21
Eligibility criteria

CKD patient stage 3a-5 (<60 ml/min/1.73 m² estimated by CKD-EPI formula) and not... [+7]

Patient for whom dialysis or transplantation is planned/expected within the next... [+12]